Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.05 (1.49%)
Spread: 0.20 (6.061%)
Open: 3.35
High: 3.40
Low: 3.35
Prev. Close: 3.35
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Panther Securities wins lease; NightCap opens new bar

Mon, 21st Feb 2022 18:12

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Forbes Ventures - Stockport, England-based investment company - Says it has experienced continued delays in listing and closing the GBP40 million two-year notes before the end of 2021. It also intends to re-domicile to the UK from the Cayman Islands where it is currently registered. Forbes Ventures says this will remove a significant cost and administrative burden from the company.

----------

Next Fifteen Communications Group PLC - London-based business growth consultant - Confirms that it is in discussion with London-based marketing company Engine UK and its owners for a potential acquisition. Next Fifteen adds that there is no certainty an acquisition of Engine UK will take place.

----------

Hargreaves Services PLC - Durham, England-based land, property and infrastructure development company - Announces that it has exchanged conditional contracts with Aver Property Ltd Partnership for the development and sale of two large distribution units. The company says that on completion the two contracts will generate revenue in excess of GBP50 million. The contracts will be a 50/50 joint venture between Hargreaves Services and Waystone Hargreaves Land LLP. The company also exchanges another conditional contract for the sale of 4.6 acres to Ogilvie Homes.

----------

Agronomics Ltd - Isle of Man, UK-based cellular agriculture company - Acquires 1.1 million shares in California-based protein producer Geltor Inc for a total consideration of USD9.5 million. This represents a 2% stake in the cosmetic industry-focused company. Co-founder Jim Mellon says: "Agronomics is thrilled to be broadening its portfolio to include Geltor, recognised as a leading precision fermentation company and one of the first companies in the sector to utilise this technology for the development of agricultural products without the need for animals."

----------

Savannah Energy PLC - London-based energy company focused on Africa - Says its Accugas subsidiary has signed a new gas sales agreement with gas distributor Central Horizon Gas Co. Central Horizon is a subsidiary of Lagos-based gas distributor and developer Axxela Ltd. Central Horizon operates a 17 kilometre gas pipeline infrastructure network with a throughput capacity of 50 million standard cubic feet of gas per day. Under the agreement, Central Horizon can be nominated to deliver up to 5 million standard cubic feet of gas per day. The agreement is for an initial one-year period but is extendable by mutual agreement. First gas deliveries are expected to commence within the next 12 months, Savannah adds.

----------

88 Energy Ltd - Western Australia-based oil exploration company focused on Alaska - Acquires a 73% net non-operated working interest in the leases and wells in established onshore production assets within the Permian Basin of Texas, US. Lonestar I LLC will retain a 24% net working interest in the assets, and through an affiliate will remain the operator. The purchase price for the acquisition is USD9.7 million, comprising USD7.2 million in cash and USD2.5 million in 88 Energy shares, approximately 98.1 million shares at an issue price of AUD0.035 per share. 88 Energy says the acquisition delivers immediate cash flows, with current gross production from the project of approximately 300 barrels of oil equivalent per day.

----------

Venture Life Group PLC - Berkshire, England-based self-care product manufacturer and distributor - Announces that a clinical trial led by Cardiff University indicate that a mouthwash containing its antimicrobial agent Cetylpyridinium Chloridecan technology can inactivate Covid-19 in the mouth for up to 1 hour. The clinical study was part-funded by Venture Life but the company says it had no input in the design, data analysis or drafting of the research paper.

----------

Oriole Resources PLC - London-based gold exploration company focused in Cameroon and Senegal - Receives notice from joint-venture partner IAMGOLD Corp confirming that it has exercised the first option in option agreement and has subsequently acquired a 51% interest in the Senala gold project in Senegal. This comes as a result of IAMGOLD reaching the USD4 million expenditure threshold within the first four years of the agreement. IAMGOLD has the option to earn a 70% interest in the project.

----------

Emmerson PLC - London-based potash developer focused in Morocco - Appoints Jim Wynn as its chief financial officer with immediate effect. Wynn had previously been CFO at London-based, Zambia-focused mining company Moxico Resources PLC as well as at Guernsey, UK-based earth metals producer Rainbow Rare Earths Ltd. He also serves of the board of London-based exploration company GreenRoc Mining PLC.

----------

Nightcap PLC - London-based- Announces a number of additional planned bar openings in 2022. The latest opening is for The Cocktail Club brand and will be located in Exeter. The bar will be licenced until 2am and will have a capacity of 200 people. Another bar in Cardiff is expected to open in April. Nightcap says it has a further 24 premises under offer or in legal negotiations and continues to see favourable market conditions for site acquisitions across the country. The company adds that it expects to publish its interim results on March 14.

----------

Kanabo Group PLC - Tel Aviv-based medical cannabis company - Acquires GP Service Ltd, a UK-based private telemedicine provider, for a total consideration of GBP13.5 million. Pursuant to a sale and purchase agreement, Kanabo will issue 106.7 million shares at a price of 12.65 pence, representing 22% of the company. The company also announces it has raised GBP2.3 million via a placing of 28.1 million shares at a price of 8p per share. The placing was completed by the company's broker Peterhouse Capital Ltd.

----------

Premier African Minerals Ltd - British Virgin Islands-based metals and minerals project developer - Reports bore hole ZDD035R at its Zulu Lithium & Tantalum Project has intersected 21.1 metres from 37.1 metres at an average grade of 1.2% lithium oxide and 920 rubidium parts per million. Bore hole ZDD036 intersects 20.72 metres from 21.66 metres at an average grade of 1.4% lithium oxide and 4,318 rubidium parts per million.

----------

Panther Securities PLC - London-based property investment company - Signs a new GBP800,000 per year lease for the majority of the Bentalls Complex in Essex, England. The property is let on a full repairing and insuring lease for a period of five years. The Bentalls Complex comprises a 200,000 square feet high bay industrial building standing on a 9-acre site.

----------

IG Design Group PLC - Bedfordshire, England-based consumer gift packaging company - Announces that Chief Executive Paul Fineman will be stepping down from March 1 due to personal reasons after 17 years with the company. The company adds that it has commenced its search for Fineman's successor. Director Lance Burn will take on the role of interim chief operating officer. IG Design adds that it is in the final stages of appointing its new chief financial officer.

----------

Fusion Antibodies PLC - Belfast-based research organisation focused on antibody development - Says that Chief Executive Richard Jones has resigned resigned in order to "pursue other opportunities". Jones will remain at the company while arrangements are put in place for his successor. The company says it has begun the search for its new CEO.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.